Citation Impact
Citing Papers
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
Helicobacter pylori Induces MAPK Phosphorylation and AP-1 Activation via a NOD1-Dependent Mechanism
2009
Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease
2016
Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn’s Disease
2016
Inflammation and cancer
2002 StandoutNature
Management of Crohn's disease in adults
2001
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Functional Gastroduodenal Disorders
2006 Standout
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
2015
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms
2003
High Anti‐Helicobacter pylori Antibody Seropositivity Associated with the Combination of IL‐8–251TT and IL‐10–819TT Genotypes
2003
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis
2003
A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility
2016 Standout
Systematic review: the costs of ulcerative colitis in Western countries
2010
Guidelines for the management of inflammatory bowel disease in adults
2011
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Aberrant Mucin Assembly in Mice Causes Endoplasmic Reticulum Stress and Spontaneous Inflammation Resembling Ulcerative Colitis
2008
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Inflammatory Bowel Disease
2009 Standout
Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease
2017
Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
2004 Standout
Human immune response towards recombinant Helicobacter pylori urease and cellular fractions
2005
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation
2004
Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study
2008
Ulcerative colitis
2012 Standout
Reduced colonization of gastric mucosa by Helicobacter pylori in mice deficient in interleukin‐101
2001
Host Response and Vaccine Development to Helicobacter pylori Infection
1999
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma
2003
Intestinal mucosal barrier function in health and disease
2009 Standout
Epidemiology of inflammatory bowel disease
2002
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
The two faces of interleukin 10 in human infectious diseases
2006
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Carcinoma-associated fibroblasts provide operational flexibility in metastasis
2014
Activation of Activator Protein 1 and Stress Response Kinases in Epithelial Cells Colonized by Helicobacter pylori Encoding the cag Pathogenicity Island
1999
Ulcerative colitis
2016 Standout
Predictors of Temporary and Permanent Work Disability in Patients With Inflammatory Bowel Disease
2013
Helicobacter pyloriInfection
2002 Standout
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2−/− mice
2009 StandoutNobel
Keystone taxa as drivers of microbiome structure and functioning
2018 Standout
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease
2008 Standout
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
New targets for mucosal healing and therapy in inflammatory bowel diseases
2013
A population-based study on the incidence of inflammatory bowel disease in Oviedo (Northern Spain)
2004
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
2011
Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation
2011
The effect of 5‐year vitamin C supplementation on serum pepsinogen level and Helicobacter pylori infection
2003
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia
2004
The global burden of IBD: from 2015 to 2025
2015 Standout
Eradication of Helicobacter pylori and Resolution of Gastritis in the Gastric Mucosa of IL‐10‐Deficient Mice
2005
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Biologic agents for IBD: practical insights
2015
Medical therapy for ulcerative colitis
2000
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
A dose‐ranging, placebo‐controlled, randomized trial of alosetron in patients with functional dyspepsia
2001
Twin Study Indicates Loss of Interaction Between Microbiota and Mucosa of Patients With Ulcerative Colitis
2011
Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection
2004
The Functional Status of the Helicobacter pylori sabB Adhesin Gene as a Putative Marker for Disease Outcome
2004
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
The human microbiome: at the interface of health and disease
2012 Standout
Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China
2016
Helicobacter pyloriModulates the T Helper Cell 1/T Helper Cell 2 Balance through Phase-variable Interaction between Lipopolysaccharide and DC-SIGN
2004
Functional Analysis of thecagPathogenicity Island inHelicobacter pyloriIsolates from Patients with Gastritis, Peptic Ulcer, and Gastric Cancer
2004
Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats
2003
Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy
2004 Standout
Role of Innate Immunity inHelicobacter pylori-Induced Gastric Malignancy
2010
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
Inhibitory interactions between 5-HT3and P2X channels in submucosal neurons
2002
The Helicobacter pylori Blood Group Antigen-Binding Adhesin Facilitates Bacterial Colonization and Augments a Nonspecific Immune Response
2002
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Slowing intestinal transit by PYY depends on serotonergic and opioid pathways
2004
Introduction to the human gut microbiota
2017 Standout
Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand Complexes
2006 Standout
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate
2002
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Inflammatory Bowel Disease
2010 Standout
Modulation of Innate Cytokine Responses by Products ofHelicobacter pylori
2000
Structure of the human gastric bacterial community in relation to Helicobacter pylori status
2010
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41
2008 Standout
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
The selectivity of protein kinase inhibitors: a further update
2007 Standout
Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response
2009 StandoutNobel
Human Dendritic Cells Respond to Helicobacter pylori, Promoting NK Cell and Th1-Effector Responses In Vitro
2004
The Disease Spectrum ofHelicobacter Pylori: The Immunopathogenesis of Gastroduodenal Ulcer and Gastric Cancer
2000
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
2011 Standout
Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function
2003
Works of Keith Bodger being referenced
Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-Control questionnaire
2013
Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion.
1997
Variation in Serum Pepsinogens With Severity and Topography of Helicobacter pylori‐Associated Chronic Gastritis in Dyspeptic Patients Referred for Endoscopy
2001
Helicobacter pyloriand gastric inflammation
1998
Interleukin 10 in Helicobacter pylori associated gastritis: immunohistochemical localisation and in vitro effects on cytokine secretion
2001
The Role of Matrix Metalloproteinase-7 in Redefining the Gastric Microenvironment in Response to Helicobacter pylori
2006
Cost Effectiveness of Treatments for Inflammatory Bowel Disease
2011
Cost of Illness of Crohn??s Disease
2002
Economic Implications of Biological Therapies for Crohn???s Disease
2005
Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients
2006
Cost‐effectiveness of biological therapy for Crohn’s disease: Markov cohort analyses incorporating United Kingdom patient‐level cost data
2009
Economic burden of inflammatory bowel disease: a UK perspective
2006
Clinical economics review: medical management of inflammatory bowel disease
1999
Dyspepsia workload in urban general practice and implications of the British Society of Gastroenterology Dyspepsia Guidelines (1996)
2000
New and emerging treatments for ulcerative colitis: a focus on vedolizumab
2013